830 related articles for article (PubMed ID: 12491511)
1. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
[TBL] [Abstract][Full Text] [Related]
2. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
[TBL] [Abstract][Full Text] [Related]
3. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
[TBL] [Abstract][Full Text] [Related]
6. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
[TBL] [Abstract][Full Text] [Related]
7. Preclinical validation of a monochrome real-time multiplex assay for translocations in childhood acute lymphoblastic leukemia.
Siraj AK; Ozbek U; Sazawal S; Sirma S; Timson G; Al-Nasser A; Bhargava M; El Solh H; Bhatia K; Gutiérrez MI
Clin Cancer Res; 2002 Dec; 8(12):3832-40. PubMed ID: 12473597
[TBL] [Abstract][Full Text] [Related]
8. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.
Viehmann S; Teigler-Schlegel A; Bruch J; Langebrake C; Reinhardt D; Harbott J
Leukemia; 2003 Jun; 17(6):1130-6. PubMed ID: 12764380
[TBL] [Abstract][Full Text] [Related]
10. Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
László R; Alpár D; Kajtár B; Lacza A; Ottóffy G; Kiss C; Bartyik K; Nagy K; Pajor L
Pediatr Blood Cancer; 2010 Jan; 54(1):158-60. PubMed ID: 19813247
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.
Scholl C; Schlenk RF; Eiwen K; Döhner H; Fröhling S; Döhner K;
Haematologica; 2005 Dec; 90(12):1626-34. PubMed ID: 16330435
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
[TBL] [Abstract][Full Text] [Related]
13. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
[TBL] [Abstract][Full Text] [Related]
14. [Study of TEL-AML1 fusion gene in childhood B-lineage acute lymphoblastic leukemia].
Niu C; Huang W; Su X
Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):61-4. PubMed ID: 11601199
[TBL] [Abstract][Full Text] [Related]
15. [Study of the childhood acute lymphoblastic leukemia with t(12;21)].
Lin D; Liu SH; Zhu XF; Bo LJ; Li CW; Chen YM; Liu XP; Qin S; Dai Y; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):17-21. PubMed ID: 14990071
[TBL] [Abstract][Full Text] [Related]
16. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
Peter A; Heiden T; Taube T; Körner G; Seeger K
Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
[TBL] [Abstract][Full Text] [Related]
17. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
[TBL] [Abstract][Full Text] [Related]
18. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
[TBL] [Abstract][Full Text] [Related]
19. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
[TBL] [Abstract][Full Text] [Related]
20. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
Tiensiwakul P
Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
